CN104958530A - Traditional Chinese medicinal composition for treating infantile pneumonia - Google Patents
Traditional Chinese medicinal composition for treating infantile pneumonia Download PDFInfo
- Publication number
- CN104958530A CN104958530A CN201510451412.1A CN201510451412A CN104958530A CN 104958530 A CN104958530 A CN 104958530A CN 201510451412 A CN201510451412 A CN 201510451412A CN 104958530 A CN104958530 A CN 104958530A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- medicine composition
- infantile pneumonia
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal composition for treating infantile pneumonia and belongs to the field of traditional Chinese medicines. The traditional Chinese medicinal composition for treating the infantile pneumonia is prepared from the following active ingredient raw materials in parts by weight: 30-90 parts of momordica grosvenori, 15-60 parts of bulbus fritillariae cirrhosae, 30-90 parts of dandelion, 5-30 parts of coptis chinensis, 30-90 parts of platycodon grandiflorum, 30-90 parts of houttuynia cordata, 20-60 parts of radix pseudostellariae and 20-60 parts of poria cocos. The eight Chinese herbal medicines are dialectical in prescription, assist each other and take synergic effect, and the effects of clearing away heat and toxic materials, relieving cough, reducing sputum, inducing diuresis to alleviate edema, relieving asthma and restlessness, eliminating pathogens and strengthening vital qi, so that effective treatment on the infantile pneumonia is realized.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly a kind of Chinese medicine composition for the treatment of infantile pneumonia.
Technical background
Infantile pneumonia is a kind of commonly encountered diseases, the pulmonary disease of system caused by different pathogens or other factors, fixing moist rales with heating, cough, tachypnea, dyspnea and pulmonary is its common clinical, is modal pediatric disease, the first cause of Ye Shi developing country death of child.
Primary disease belongs to the category that traditional Chinese medical science pneumonia asthma is coughed, be the gas owing to experiencing six climate exopathogens, invade lung meridian, or eating and drinking without temperance, lung spleen deficiency in origin, raw wet wine expectorant, stops up stagnant lung network, meets and leak and trigger, heresy is caused to close lung network, impairment of purifying function of the lung, seriously can cause qi depression to blood stasis, wind heat closes lung or phlegm-heat closed lung etc., and normal with the infantile pneumonia deficiency syndrome such as asthenia of pulmonosplenic qi, deficiency of YIN lung-heat.
At present, infantile pneumonia mainly adopts doctor trained in Western medicine antiinflammatory, cough-relieving, treatment of relievining asthma, although this Therapeutic Method curative effect certainly, also the treatment of infantile pneumonia can be met, Drug therapy mainly selects antibiotic, such as erythromycin, penicillin, lincomycin, cefotaxime, hydroxylation ampicillin, Flemoxin etc.; Antiviral therapy mainly uses ribavirin or acycloguanosine to carry out sterilizing in body toxin expelling to patient.But widely use due to antibiotic, the drug resistance of antibacterial and gram-negative bacteria and viral infection are increased, makes the treatment of pneumonia day by day difficult.
Summary of the invention
The object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, to the Chinese medicine composition of the treatment infantile pneumonia of human non-toxic's side effect.
The technical scheme that technical solution problem of the present invention is taked is:
Treat a Chinese medicine composition for infantile pneumonia, the raw material composition of described Chinese medicine composition effective ingredient and parts by weight are:
Fructus Momordicae 30-90 Bulbus Fritillariae Cirrhosae 15-60 Herba Taraxaci 30-90 Rhizoma Coptidis 5-30
Radix Platycodonis 30-90 Herba Houttuyniae 30-90 Radix Pseudostellariae 20-60 Poria 20-60
Preferably, described Chinese medicine composition effective ingredient raw material composition and parts by weight be:
Fructus Momordicae 60 Bulbus Fritillariae Cirrhosae 25 Herba Taraxaci 60 Rhizoma Coptidis 10
Radix Platycodonis 30 Herba Houttuyniae 60 Radix Pseudostellariae 40 Poria 40
Preferably, described Chinese medicine composition effective ingredient raw material composition and parts by weight be:
Fructus Momordicae 45 Bulbus Fritillariae Cirrhosae 30 Herba Taraxaci 90 Rhizoma Coptidis 25
Radix Platycodonis 40 Herba Houttuyniae 40 Radix Pseudostellariae 40 Poria 40
Preferably, described Chinese medicine composition effective ingredient raw material composition and parts by weight be:
Fructus Momordicae 30 Bulbus Fritillariae Cirrhosae 15 Herba Taraxaci 30 Rhizoma Coptidis 15
Radix Platycodonis 45 Herba Houttuyniae 45 Radix Pseudostellariae 30 Poria 30
Be used for the treatment of a preparation method for the Chinese medicine composition of infantile pneumonia, comprise following processing step:
Take Fructus Momordicae, Bulbus Fritillariae Cirrhosae, Herba Taraxaci, Rhizoma Coptidis, Radix Platycodonis, Herba Houttuyniae, Radix Pseudostellariae, Poria, pulverize, mix homogeneously, add 6-12 distilled water doubly, soak 2 hours, backflow decoction 3 times, each 1-3 hour, filter, mix 3 filtrates, add crystal sugar heating for dissolving, concentrated filtrate, add maltose and be constantly uniformly mixed into syrup with Mel, make every milliliter of syrup containing crude drug 0.5-1.0g.
Certain the present invention also can adopt conventional decocting method to take, and existing preparation process is prepared into any one traditional oral preparation.
The property of medicine of the present invention's Chinese medicine used is as follows:
Fructus Momordicae: another name LAHANGUO, Herba Cardiospermi Halicacabi, Semen Momordicae, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae), arhat table, naked Testudinis bar, being described as " angle fruit " by people, is the key medicine of relieving cough and resolving phlegm.Sweet in the mouth is cool.Return lung, large intestine channel.Clearing heat and moistening lung, laxation relieving constipation.For lung-fire cough caused by dryness, pharyngalgia aphonia, dryness of the intestine constipation.
Bulbus Fritillariae Cirrhosae: bitter in the mouth, sweet, is slightly cold.Gui Jing returns lung, heart channel.Clearing heat and moistening lung, preventing phlegm from forming and stopping coughing.For lung-heat type cough, the few expectorant of dry cough, deficiency of YIN chronic cough, sputum with blood.
Herba Taraxaci: bitter in the mouth, sweet, cold.Return liver, stomach warp.Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, inducing diuresis for treating stranguria syndrome.For furuncle swelling toxin, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, lung abscess, acute appendicitis, jaundice due to damp-heat, the puckery pain of pyretic stranguria.
Rhizoma Coptidis: bitter in the mouth, cold.GUIXIN, spleen, stomach, liver, gallbladder, large intestine channel.Heat clearing and damp drying, eliminating fire and detoxication.For damp and hot feeling of fullness, vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood tells nosebleed, conjunctival congestion, and toothache, quenches one's thirst, carbuncle furuncle; External treatment eczema, eczema, auditory meatus is suppurated.
Radix Platycodonis: bitter in the mouth, pungent is flat.Return lung meridian.Lung qi dispersing, sore-throat relieving, eliminates the phlegm, evacuation of pus.For cough with copious phlegm, uncomfortable in chest not smooth, pharyngalgia, hoarseness, lung abscess vomiting pus, skin infection difficulty in discharging of pus.
Herba Houttuyniae: acrid in the mouth, is slightly cold.Return lung meridian.Heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, inducing diuresis for treating stranguria syndrome.For lung abscess vomiting pus, expectorant dyspnea of heat type is coughed, hematodiarrhoea, pyretic stranguria, carbuncle sore tumefacting virus.
Radix Pseudostellariae: sweet in the mouth, micro-hardship is flat.Return spleen, lung meridian.Replenishing QI to invigorate the spleen, promoting the production of body fluid for nourishing the lung.Tired for insufficiency of the spleen body, inappetence, weak after being ill, deficiency of both vital energy and Yin, spontaneous perspiration is thirsty, dryness of the lung dry cough.
Poria: sweet in the mouth, light is flat.GUIXIN, lung, spleen, kidney channel.Promoting diuresis to eliminate damp pathogen, spleen invigorating mind calming.For edema oliguria, phlegm retention vertigo and palpitation, insufficiency of the spleen lack of appetite, have loose bowels in loose stool, irritability, palpitation with fear insomnia.
In Chinese prescription of the present invention, Fructus Momordicae is described as " angle fruit " by people, and be the key medicine of relieving cough and resolving phlegm, sweet in the mouth is cool in nature, has clearing heat and moistening lung, cough-relieving sore-throat relieving, and clearing away lung-heat is except restlessness and coughing, and effect of inducing diuresis to remove edema, is " monarch drug ".Herba Taraxaci, Herba Houttuyniae, Rhizoma Coptidis, Bulbus Fritillariae Cirrhosae all have the merit of heat-clearing and toxic substances removing, inducing diuresis to remove edema, relieving cough and asthma, anti-inflammatory antipyretic, are " ministerial drug ".Radix Pseudostellariae is put down, and returns spleen, lung meridian, can replenishing QI to invigorate the spleen, and promoting the production of body fluid for nourishing the lung, can play the effect of " righting of getting rid of evils ".The pungent loose hardship of Radix Platycodonis is let out, and property is gentle, kind up, specially walks lung meridian, kindly opens lung qi dispersing gas, reduce phlegm the chest stuffiness relieving and control cough with copious phlegm, is the key medicine of lung meridian edema caused by disorder of QI.Poria is apt to spleen invigorating and oozes and sluice wet, makes wetly to gather without institute, and expectorant is had no way of life, therefore can treat the dizzy cardiopalmus of phlegm retention and drink and be stopped at stomach and vomiter, and above flavour of a drug are " assistant makes " altogether.Above-mentioned 8 taste Chinese herbal medicine through dialectical prescription, mutually assist a ruler in governing a country, can Synergistic, reach effect of heat-clearing and toxic substances removing, relieving cough and resolving phlegm, inducing diuresis to remove edema, relieving restlessness of relievining asthma, righting of getting rid of evils, thus realize the effective treatment to infantile pneumonia.
Compared with prior art, it is few that Chinese medicine composition of the present invention has medication, and therapeutic effect is good, cure rate is high, without any side effects etc. significantly treats advantage; In addition, its preparation technology is simple and easy to do, its preparation stabilization, be convenient for carrying, and is beneficial to large-scale production.
Detailed description of the invention
Further describe the present invention below by way of specific embodiment, but the present invention is not limited only to following specific embodiment.Within the scope of the invention or not departing from content of the present invention, spirit and scope, the change carried out the present invention, combination or replacement, be apparent for a person skilled in the art, and be included within the scope of the present invention.
Embodiment 1
Prescription (weight portion):
Fructus Momordicae 60 Bulbus Fritillariae Cirrhosae 25 Herba Taraxaci 60 Rhizoma Coptidis 10
Radix Platycodonis 30 Herba Houttuyniae 60 Radix Pseudostellariae 40 Poria 40
Preparation method: take Fructus Momordicae, Bulbus Fritillariae Cirrhosae, Herba Taraxaci, Rhizoma Coptidis, Radix Platycodonis, Herba Houttuyniae, Radix Pseudostellariae, Poria, pulverizes, mix homogeneously, add the distilled water of 10 times, soak 2 hours, backflow decoction 3 times, each 2 hours, filter, mix 3 filtrates, add crystal sugar heating for dissolving, concentrated filtrate, add maltose and be constantly uniformly mixed into syrup with Mel, make every milliliter of syrup containing crude drug 0.5g.
Embodiment 2
Prescription (weight portion):
Fructus Momordicae 45 Bulbus Fritillariae Cirrhosae 30 Herba Taraxaci 90 Rhizoma Coptidis 25
Radix Platycodonis 40 Herba Houttuyniae 40 Radix Pseudostellariae 40 Poria 40
Preparation method: take Fructus Momordicae, Bulbus Fritillariae Cirrhosae, Herba Taraxaci, Rhizoma Coptidis, Radix Platycodonis, Herba Houttuyniae, Radix Pseudostellariae, Poria, pulverizes, mix homogeneously, add the distilled water of 8 times, soak 2 hours, backflow decoction 3 times, each 2 hours, filter, mix 3 filtrates, add crystal sugar heating for dissolving, concentrated filtrate, add maltose and be constantly uniformly mixed into syrup with Mel, make every milliliter of syrup containing crude drug 0.5g.
Embodiment 3
Prescription (weight portion):
Fructus Momordicae 30 Bulbus Fritillariae Cirrhosae 15 Herba Taraxaci 30 Rhizoma Coptidis 15
Radix Platycodonis 45 Herba Houttuyniae 45 Radix Pseudostellariae 30 Poria 30
Preparation method: take Fructus Momordicae, Bulbus Fritillariae Cirrhosae, Herba Taraxaci, Rhizoma Coptidis, Radix Platycodonis, Herba Houttuyniae, Radix Pseudostellariae, Poria, pulverizes, mix homogeneously, add the distilled water of 10 times, soak 2 hours, backflow decoction 3 times, each 2 hours, filter, mix 3 filtrates, add crystal sugar heating for dissolving, concentrated filtrate, add maltose and be constantly uniformly mixed into syrup with Mel, make every milliliter of syrup containing crude drug 1.0g.
Embodiment 4
Prescription (weight portion):
Fructus Momordicae 60 Bulbus Fritillariae Cirrhosae 60 Herba Taraxaci 60 Rhizoma Coptidis 30
Radix Platycodonis 90 Herba Houttuyniae 60 Radix Pseudostellariae 60 Poria 60
Preparation method: take Fructus Momordicae, Bulbus Fritillariae Cirrhosae, Herba Taraxaci, Rhizoma Coptidis, Radix Platycodonis, Herba Houttuyniae, Radix Pseudostellariae, Poria, pulverizes, mix homogeneously, add the distilled water of 10 times, soak 2 hours, backflow decoction 3 times, each 2 hours, filter, mix 3 filtrates, add crystal sugar heating for dissolving, concentrated filtrate, add maltose and be constantly uniformly mixed into syrup with Mel, make every milliliter of syrup containing crude drug 0.75g.
Embodiment 5
Prescription (weight portion):
Fructus Momordicae 30 Bulbus Fritillariae Cirrhosae 15 Herba Taraxaci 30 Rhizoma Coptidis 5
Radix Platycodonis 30 Herba Houttuyniae 30 Radix Pseudostellariae 20 Poria 20
Preparation method: take Fructus Momordicae, Bulbus Fritillariae Cirrhosae, Herba Taraxaci, Rhizoma Coptidis, Radix Platycodonis, Herba Houttuyniae, Radix Pseudostellariae, Poria, pulverizes, mix homogeneously, add the distilled water of 12 times, soak 2 hours, backflow decoction 3 times, each 2 hours, filter, mix 3 filtrates, add crystal sugar heating for dissolving, concentrated filtrate, add maltose and be constantly uniformly mixed into syrup with Mel, make every milliliter of syrup containing crude drug 0.5g.
Animal toxicity is tested
1. acute toxicity test
Application mice carries out acute toxicity testing and shows: mouse stomach Chinese medicine composition syrup of the present invention, under 500 crude drugs/kg body weight dose, after administration, mice occurs that light activity reduces, 1 hours recovers normal, Continuous Observation 7 days after administration, none animal dead, its overall health of patients, diet, take the photograph water, urine and body weight increase all normal, experimental result shows: the maximum dosage-feeding of Mouse oral gavage Chinese medicine composition syrup of the present invention is 500 crude drugs/kg/d(LD 50 > 500g crude drug/kg).Be 0.1g crude drug/kg/d by Chinese medicine composition clinical application every day total amount of the present invention; By weighing machine, the dosis tolerata of mouse stomach Chinese medicine composition of the present invention is 5000 times of clinical patient.Point out this medicine acute toxicity low, clinical drug safety.
2. long term toxicity test
Select SD rat, give the Chinese medicine composition syrup of the present invention of variable concentrations (20.0,10.0,1.0g crude drug/kg), every day gavage once, continuous 90 days, within after last administration 24 hours, respectively group is alive kills 1/2 animal (male and female half and half), and all the other 1/2 animals continue observations 2 weeks rear living and kill.Duration of test observes outward appearance, general behavior, food ration, the body weight change of animal, within after administration 90 days, within 2 weeks, carries out the index checking such as hematology's (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemical (AST, ALT, ALP, Glu, BUN, Crea, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology with drug withdrawal.Result of the test shows: Chinese medicine composition of the present invention is good at high, medium and low dosage treated animal general state, and outward appearance sign, behavioral activity, food-intake and body weight increase change all without exception; Three dosage groups and matched group hematological examination, blood biochemical analysis, urine biochemical analysis all in normal range, without significant difference between group; Each group of main organs histopathological examination shows no obvious abnormalities.These parameters drug withdrawal also had no change after 2 weeks.This test dosage is respectively 200,100,10 times of clinical medicine dose, rat is had no significant effect in high, medium and low three dosage (20.0,10.0,1.0g crude drug/kg) administration in continuous 90 days according to result of the test Chinese medicine composition of the present invention, without clear and definite toxicity target organ and sensitive indicator, convalescent period observation also has no retardance toxic reaction, points out Chinese medicine composition clinical practice dosage safety of the present invention.
Clinical research test of the present invention:
1. physical data
Select year May in May, 2011 to 2015 certain hospital clinic of city be diagnosed as infantile pneumonia patient 212 example, the age between 0.8 years old-12 years old, average 4.8 years old; Wherein man 113 example, female 99 example; Course of disease 1-30 days.Most of infant once repeatedly suffered from infantile pneumonia, and once repeatedly with Chinese and western drugs treatment, though the state of an illness is clearly better, repeatedly suffered from infantile pneumonia.
2. diagnostic criteria
(1) onset is comparatively anxious, the lighter's fever and cough, abundant expectoration between larynx, severe one rapid breathing, flaring of nares, and dysphoria appears in severe patient, pale complexion, steel gray or cyanosis of the lips and nails, and extremity are not warm or faint cold, and liver increases in a short time; Or lasting high fever is endlessly, unconsciousness and delirium, tic of the limbs.The above-mentioned partial symptoms of young infant of neonatal, ferritic gas YANG deficiency can not be true to type.
(2) auscultation of lung audible and middle fine crackles.
(3) chest X ray examination enhanced lung markings, disorder, visible strip, patch shape shade, or see uneven large lamellar shade.
(4) other hearts, lung disease (as pulmonary tuberculosis, asthma, bronchiectasis, pulmonary carcinoma, heart disease etc.) person can be got rid of.
3. observation index
One is observe infant spirit, diet, body temperature, tachypnea emergency of panting, cough degree and frequency, and expectoration quantity, expectorant color change, and auscultation pulmonary rale changes; Two is observe infant chest x-ray to change.
4. Therapeutic Method
212 routine patients are divided into two groups at random, and often organize 106 examples, two groups of ages, sex, courses of disease etc. are through statistical procedures (P>0.05) there was no significant difference.
Two groups of patients all give western medicine routine treatment: by infection, cough-relieving, reduce phlegm, the conventional therapy such as to relieving asthma; Treatment group adds the syrup treatment with the embodiment of the present invention 1 formula preparation.1-3 year, every day 2-4ml, 4-6 year, every day 4-6ml; 7-9 year, every day 6-8ml; More than 10, every day 10ml.Therapeutic outcome is added up after 5 days.
5. clinical efficacy evaluation criteria
With reference to the efficacy assessment standard of " disease of tcm Standardization of diagnosis and curative effect TCM Pediatrics Illnesses Diagnoses criterion of therapeutical effect " interior pneumonia cough that State Administration of Traditional Chinese Medicine issues for 1994.
(1) fully recover: symptom, sign disappear substantially, and primary symptom integration is 0;
(2) effective: symptom, sign disappear mostly, primary symptom integration reduces >=2/3;
(3) take a turn for the better: symptom, sign alleviate, primary symptom integration reduces >=1/3, but < 2/3;
(4) invalid: symptom, sign are without significant change or increase the weight of, primary symptom integration reduces.
6. therapeutic outcome:
6.1 liang of group comparitive study
Clinical efficacy comparison after table 1 liang group treatment
Compare with matched group
*p < 0.05.
The cure rate for the treatment of group and matched group is respectively 89.6% and 68.9%, and through statistical procedures, P < 0.05, difference has statistical significance.The total effective rate for the treatment of group and matched group is respectively 99.1% and 89.6%, and through statistical procedures, P < 0.05, difference also has statistical significance.
The comparison again occurring pulmonary infection in 6 months is followed up a case by regular visits to after 6.2 treatments
Again there is the comparison of pulmonary infection in table 2 liang group
Wherein treatment group has 17 examples, matched group has 22 examples cannot follow up a case by regular visits to because of a variety of causes, and treatment group and the total reinfection rate of matched group are respectively 4.5% and 39.3%, and through statistical procedures, P < 0.01, difference has pole significance.
Clinical trial results shows: in conjunction with conventional western medicine treatment infantile pneumonia, the medicine particularly prepared by embodiment 1 formula of Chinese medicine composition of the present invention has that short treating period, medication are few, recurrence less and the feature had no side effect.
Claims (7)
1. treat a Chinese medicine composition for infantile pneumonia, it is characterized in that, the raw material composition of described Chinese medicine composition effective ingredient and parts by weight are:
Fructus Momordicae 30-90 Bulbus Fritillariae Cirrhosae 15-60 Herba Taraxaci 30-90 Rhizoma Coptidis 5-30
Radix Platycodonis 30-90 Herba Houttuyniae 30-90 Radix Pseudostellariae 20-60 Poria 20-60.
2. the Chinese medicine composition for the treatment of infantile pneumonia as claimed in claim 1, is characterized in that, the raw material composition of described Chinese medicine composition effective ingredient and parts by weight are:
Fructus Momordicae 60 Bulbus Fritillariae Cirrhosae 25 Herba Taraxaci 60 Rhizoma Coptidis 10
Radix Platycodonis 30 Herba Houttuyniae 60 Radix Pseudostellariae 40 Poria 40.
3. the Chinese medicine composition for the treatment of infantile pneumonia as claimed in claim 1, is characterized in that, the raw material composition of described Chinese medicine composition effective ingredient and parts by weight are:
Fructus Momordicae 45 Bulbus Fritillariae Cirrhosae 30 Herba Taraxaci 90 Rhizoma Coptidis 25
Radix Platycodonis 40 Herba Houttuyniae 40 Radix Pseudostellariae 40 Poria 40.
4. the Chinese medicine composition for the treatment of infantile pneumonia as claimed in claim 1, is characterized in that, the raw material composition of described Chinese medicine composition effective ingredient and parts by weight are:
Fructus Momordicae 30 Bulbus Fritillariae Cirrhosae 15 Herba Taraxaci 30 Rhizoma Coptidis 15
Radix Platycodonis 45 Herba Houttuyniae 45 Radix Pseudostellariae 30 Poria 30.
5. as described in any one of claim 1-4, treat the Chinese medicine composition of infantile pneumonia, it is characterized in that: described Chinese medicine composition is oral formulations.
6. treat the Chinese medicine composition of infantile pneumonia as claimed in claim 5, it is characterized in that: described oral formulations is syrup.
7. prepare the method for the Chinese medicine composition being used for the treatment of infantile pneumonia as claimed in claim 1 for one kind, it is characterized in that, comprise following processing step: take Fructus Momordicae, Bulbus Fritillariae Cirrhosae, Herba Taraxaci, Rhizoma Coptidis, Radix Platycodonis, Herba Houttuyniae, Radix Pseudostellariae, Poria, pulverize, mix homogeneously, add 6-12 distilled water doubly, soak 2 hours, backflow decoction 3 times, each 1-3 hour, filter, mix 3 filtrates, add crystal sugar heating for dissolving, concentrated filtrate, add maltose and be constantly uniformly mixed into syrup with Mel, make every milliliter of syrup containing crude drug 0.5-1.0g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510451412.1A CN104958530A (en) | 2015-07-29 | 2015-07-29 | Traditional Chinese medicinal composition for treating infantile pneumonia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510451412.1A CN104958530A (en) | 2015-07-29 | 2015-07-29 | Traditional Chinese medicinal composition for treating infantile pneumonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104958530A true CN104958530A (en) | 2015-10-07 |
Family
ID=54212733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510451412.1A Withdrawn CN104958530A (en) | 2015-07-29 | 2015-07-29 | Traditional Chinese medicinal composition for treating infantile pneumonia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104958530A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111388642A (en) * | 2020-04-17 | 2020-07-10 | 吕守忠 | Traditional Chinese medicine composition for treating cough |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152386A (en) * | 2007-09-24 | 2008-04-02 | 范玉堂 | Traditional Chinese medicine for treating children's pulmonitis asthma and cough |
| CN101152507A (en) * | 2007-09-28 | 2008-04-02 | 丁文生 | Traditional Chinese medicine for treating asthenic healthy qi with pathogen lingering type children's pulmonitis |
| CN101579472A (en) * | 2008-05-18 | 2009-11-18 | 宗世玲 | Traditional Chinese medicine for treating infantile pneumonia |
| CN102120010A (en) * | 2011-02-21 | 2011-07-13 | 田荣春 | Medicament for treating children pneumonia |
| CN103479872A (en) * | 2013-09-30 | 2014-01-01 | 李长沛 | Medicament for treating infantile pneumonia |
| CN104161965A (en) * | 2013-05-17 | 2014-11-26 | 张学亮 | Traditional Chinese medicine composition for treating children's pneumonia |
-
2015
- 2015-07-29 CN CN201510451412.1A patent/CN104958530A/en not_active Withdrawn
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152386A (en) * | 2007-09-24 | 2008-04-02 | 范玉堂 | Traditional Chinese medicine for treating children's pulmonitis asthma and cough |
| CN101152507A (en) * | 2007-09-28 | 2008-04-02 | 丁文生 | Traditional Chinese medicine for treating asthenic healthy qi with pathogen lingering type children's pulmonitis |
| CN101579472A (en) * | 2008-05-18 | 2009-11-18 | 宗世玲 | Traditional Chinese medicine for treating infantile pneumonia |
| CN102120010A (en) * | 2011-02-21 | 2011-07-13 | 田荣春 | Medicament for treating children pneumonia |
| CN104161965A (en) * | 2013-05-17 | 2014-11-26 | 张学亮 | Traditional Chinese medicine composition for treating children's pneumonia |
| CN103479872A (en) * | 2013-09-30 | 2014-01-01 | 李长沛 | Medicament for treating infantile pneumonia |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111388642A (en) * | 2020-04-17 | 2020-07-10 | 吕守忠 | Traditional Chinese medicine composition for treating cough |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102048933B (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
| CN101972338B (en) | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof | |
| CN102198262B (en) | Chinese medicine preparation for treating infant rotavirus enteritis and preparation method thereof | |
| CN102772781A (en) | Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof | |
| CN102847021B (en) | Enema for treating ulcerative colitis and preparation method thereof | |
| CN102188685A (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN104324125A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN104147194B (en) | Traditional Chinese medicine composition for treating chronic sinusitis | |
| CN104706953A (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
| CN104983968A (en) | Pyretolysis traditional Chinese medicine composition and preparation method | |
| CN104524174A (en) | Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof | |
| CN105381335B (en) | A kind of drug for treating eczema | |
| CN104784470B (en) | A kind of Chinese medicine composition for the treatment of infantile pneumonia | |
| CN104958530A (en) | Traditional Chinese medicinal composition for treating infantile pneumonia | |
| CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN104116960A (en) | Traditional Chinese medicinal preparation for treating hand-foot-and-mouth disease | |
| CN105056078A (en) | Traditional Chinese medicine composition for treating stomach fire exuberance, toothache and ozostomia | |
| CN104800675A (en) | Medicament for treating active ulcerative colitis | |
| CN103494924B (en) | Chinese medicine composition for treating damp-heat stagnation acne | |
| CN104173480A (en) | Traditional Chinese medicine composition for treating infantile suppurative tonsillitis | |
| CN102641442B (en) | Traditional Chinese medicine preparation for treating recurrent aphthae | |
| CN105250746A (en) | Heat clearing and toxin removing oral liquid and preparation method thereof | |
| CN105147909A (en) | Chinese herb decoction for treating meningitis and preparation method thereof | |
| CN104707124A (en) | Traditional Chinese medicine preparation for treating chronic endometritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151007 |
|
| WW01 | Invention patent application withdrawn after publication |